06622 兆科眼科－Ｂ
按盘价 
3.040 +0.020 (+0.662%) 盈利能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 资产回报率 (%) | -10.002% | -10.184% | -15.429% | -15.739% | -111.158% |
| 股东资金回报率 (%) | -12.024% | -12.030% | -17.515% | -16.818% | -243.470% |
| 资本运用回报率 (%) | -13.005% | -12.302% | -18.477% | -17.142% | -84.636% |
边际利润分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 毛利率 (%) | 50.206% | 74.717% | 75.984% | N/A | N/A |
| 未计利息、税项、折旧及摊销前利润率 (%) | -600.303% | -360.128% | -2161.397% | N/A | N/A |
| 税前边际利润率 (%) | -653.600% | -342.584% | -2050.603% | N/A | N/A |
| 纯利率 (%) | -653.600% | -342.584% | -2053.536% | N/A | N/A |
变现能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 流动比率 (X) | 4.183 X | 5.159 X | 5.334 X | 10.141 X | 24.817 X |
| 速动比率 (X) | 4.139 X | 5.111 X | 5.316 X | 10.141 X | 24.817 X |
财务杠杆分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 总负债 / 总资产比率 (%) | 18.572% | 15.308% | 15.371% | 8.646% | 4.219% |
| 总债项 / 总资产比率 (%) | 15.107% | 10.635% | 9.834% | 5.132% | 1.421% |
| 净债项 / 总资产比率 (%) | -34.462% | -39.332% | -50.555% | -61.636% | -80.271% |
| 总债项 / 股东资金比率 (%) | 18.552% | 12.557% | 11.621% | 5.618% | 1.484% |
| 长期债项 / 股东资金比率 (%) | 0.597% | 0.845% | 1.067% | 1.180% | 0.836% |
| 净债项 / 股东资金比率 (%) | -42.322% | -46.441% | -59.737% | -67.469% | -83.807% |
| 净现金 / (债项) ($) | 6.67亿 | 8.82亿 | 12.24亿 | 15.84亿 | 20.91亿 |
| 每股净现金 / (债项) ($) | 1.217 | 1.616 | 2.240 | 2.913 | 3.859 |
| 总债项 / 资本运用比率 (%) | 18.194% | 12.359% | 11.422% | 5.552% | 1.472% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
营运效率分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 存货周转率日数 (日) | 338.509日 | 219.100日 | 497.771日 | N/A | N/A |
| 应收贸易帐周转率日数 (日) | 88.345日 | 13.397日 | 72.221日 | N/A | N/A |
| 应付贸易帐周转率日数 (日) | 8.499日 | 6.147日 | 22.698日 | N/A | N/A |
| 备注： | 实时报价更新时间为02/04/2026 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB -208,982 |
| 增长率 | -12.005% |
| 每股盈利/(亏损) | RMB -0.380 |
| 每股账面资产净值 (¥) | RMB 2.876 |